Surgical treatment of accessory atrioventricular pathways and symptomatic tachycardia in children and young adults
Identifieur interne : 000964 ( Main/Corpus ); précédent : 000963; suivant : 000965Surgical treatment of accessory atrioventricular pathways and symptomatic tachycardia in children and young adults
Auteurs : David R. Holmes Jr. ; Gordon K. Danielson ; Bernard J. Gersh ; Michael J. Osborn ; Douglas L. Wood ; Christopher Mclaran ; Declan D. Sugrue ; Co-Burn J. Porter ; Stephen C. HammillSource :
- The American Journal of Cardiology [ 0002-9149 ] ; 1985.
Abstract
Twenty-seven patients aged 21 years or younger (mean 15) with symptomatic tachycardia underwent operation for ablation of an accessory atrioventricular pathway. Six patients had associated Ebstein's malformation of the tricuspid valve. Supraventricular tachycardia had been present for a mean of 5 years. At electrophysiologic study, 4 patients were found to have 2 accessory pathways. Left ventricular free wall pathways were found In 14 patients, right ventricular free wall pathways in 10 and septal pathways in 6. Successful initial ablation of all the pathways was achieved in 26 of the 27 patients. No patient died perioperatively and none had persistent complete heart block. During a mean follow-up of 11 months, no patient had recurrence of an arrhythmia related to the accessory pathway. Thus, the surgical treatment of children and young adults with accessory atrioventricular pathways and symptomatic supraventricular tachycardia is safe and effective. For these patients, unless the tachycardia can be easily controlled with a minimal number of drugs and adverse effects, surgical ablation should be considered early in the clinical course.
Url:
DOI: 10.1016/0002-9149(85)90963-4
Links to Exploration step
ISTEX:3B8186F6F2432D5880E5BAF6592D505D5D9A5479Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Surgical treatment of accessory atrioventricular pathways and symptomatic tachycardia in children and young adults</title><author><name sortKey="Holmes Jr, David R" sort="Holmes Jr, David R" uniqKey="Holmes Jr D" first="David R." last="Holmes Jr.">David R. Holmes Jr.</name><affiliation><mods:affiliation>Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA</mods:affiliation></affiliation></author><author><name sortKey="Danielson, Gordon K" sort="Danielson, Gordon K" uniqKey="Danielson G" first="Gordon K." last="Danielson">Gordon K. Danielson</name><affiliation><mods:affiliation>Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA</mods:affiliation></affiliation></author><author><name sortKey="Gersh, Bernard J" sort="Gersh, Bernard J" uniqKey="Gersh B" first="Bernard J." last="Gersh">Bernard J. Gersh</name><affiliation><mods:affiliation>Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA</mods:affiliation></affiliation></author><author><name sortKey="Osborn, Michael J" sort="Osborn, Michael J" uniqKey="Osborn M" first="Michael J." last="Osborn">Michael J. Osborn</name><affiliation><mods:affiliation>Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA</mods:affiliation></affiliation></author><author><name sortKey="Wood, Douglas L" sort="Wood, Douglas L" uniqKey="Wood D" first="Douglas L." last="Wood">Douglas L. Wood</name><affiliation><mods:affiliation>Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA</mods:affiliation></affiliation></author><author><name sortKey="Mclaran, Christopher" sort="Mclaran, Christopher" uniqKey="Mclaran C" first="Christopher" last="Mclaran">Christopher Mclaran</name><affiliation><mods:affiliation>Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA</mods:affiliation></affiliation></author><author><name sortKey="Sugrue, Declan D" sort="Sugrue, Declan D" uniqKey="Sugrue D" first="Declan D." last="Sugrue">Declan D. Sugrue</name><affiliation><mods:affiliation>Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA</mods:affiliation></affiliation></author><author><name sortKey="Porter, Co Burn J" sort="Porter, Co Burn J" uniqKey="Porter C" first="Co-Burn J." last="Porter">Co-Burn J. Porter</name><affiliation><mods:affiliation>Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA</mods:affiliation></affiliation></author><author><name sortKey="Hammill, Stephen C" sort="Hammill, Stephen C" uniqKey="Hammill S" first="Stephen C." last="Hammill">Stephen C. Hammill</name><affiliation><mods:affiliation>Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:3B8186F6F2432D5880E5BAF6592D505D5D9A5479</idno><date when="1985" year="1985">1985</date><idno type="doi">10.1016/0002-9149(85)90963-4</idno><idno type="url">https://api.istex.fr/document/3B8186F6F2432D5880E5BAF6592D505D5D9A5479/fulltext/pdf</idno><idno type="wicri:Area/Main/Corpus">000964</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Surgical treatment of accessory atrioventricular pathways and symptomatic tachycardia in children and young adults</title><author><name sortKey="Holmes Jr, David R" sort="Holmes Jr, David R" uniqKey="Holmes Jr D" first="David R." last="Holmes Jr.">David R. Holmes Jr.</name><affiliation><mods:affiliation>Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA</mods:affiliation></affiliation></author><author><name sortKey="Danielson, Gordon K" sort="Danielson, Gordon K" uniqKey="Danielson G" first="Gordon K." last="Danielson">Gordon K. Danielson</name><affiliation><mods:affiliation>Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA</mods:affiliation></affiliation></author><author><name sortKey="Gersh, Bernard J" sort="Gersh, Bernard J" uniqKey="Gersh B" first="Bernard J." last="Gersh">Bernard J. Gersh</name><affiliation><mods:affiliation>Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA</mods:affiliation></affiliation></author><author><name sortKey="Osborn, Michael J" sort="Osborn, Michael J" uniqKey="Osborn M" first="Michael J." last="Osborn">Michael J. Osborn</name><affiliation><mods:affiliation>Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA</mods:affiliation></affiliation></author><author><name sortKey="Wood, Douglas L" sort="Wood, Douglas L" uniqKey="Wood D" first="Douglas L." last="Wood">Douglas L. Wood</name><affiliation><mods:affiliation>Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA</mods:affiliation></affiliation></author><author><name sortKey="Mclaran, Christopher" sort="Mclaran, Christopher" uniqKey="Mclaran C" first="Christopher" last="Mclaran">Christopher Mclaran</name><affiliation><mods:affiliation>Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA</mods:affiliation></affiliation></author><author><name sortKey="Sugrue, Declan D" sort="Sugrue, Declan D" uniqKey="Sugrue D" first="Declan D." last="Sugrue">Declan D. Sugrue</name><affiliation><mods:affiliation>Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA</mods:affiliation></affiliation></author><author><name sortKey="Porter, Co Burn J" sort="Porter, Co Burn J" uniqKey="Porter C" first="Co-Burn J." last="Porter">Co-Burn J. Porter</name><affiliation><mods:affiliation>Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA</mods:affiliation></affiliation></author><author><name sortKey="Hammill, Stephen C" sort="Hammill, Stephen C" uniqKey="Hammill S" first="Stephen C." last="Hammill">Stephen C. Hammill</name><affiliation><mods:affiliation>Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j">The American Journal of Cardiology</title><title level="j" type="abbrev">AJC</title><idno type="ISSN">0002-9149</idno><imprint><publisher>ELSEVIER</publisher><date type="published" when="1985">1985</date><biblScope unit="volume">55</biblScope><biblScope unit="issue">13</biblScope><biblScope unit="page" from="1509">1509</biblScope><biblScope unit="page" to="1512">1512</biblScope></imprint><idno type="ISSN">0002-9149</idno></series><idno type="istex">3B8186F6F2432D5880E5BAF6592D505D5D9A5479</idno><idno type="DOI">10.1016/0002-9149(85)90963-4</idno><idno type="PII">0002-9149(85)90963-4</idno><idno type="ArticleID">85909634</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0002-9149</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Twenty-seven patients aged 21 years or younger (mean 15) with symptomatic tachycardia underwent operation for ablation of an accessory atrioventricular pathway. Six patients had associated Ebstein's malformation of the tricuspid valve. Supraventricular tachycardia had been present for a mean of 5 years. At electrophysiologic study, 4 patients were found to have 2 accessory pathways. Left ventricular free wall pathways were found In 14 patients, right ventricular free wall pathways in 10 and septal pathways in 6. Successful initial ablation of all the pathways was achieved in 26 of the 27 patients. No patient died perioperatively and none had persistent complete heart block. During a mean follow-up of 11 months, no patient had recurrence of an arrhythmia related to the accessory pathway. Thus, the surgical treatment of children and young adults with accessory atrioventricular pathways and symptomatic supraventricular tachycardia is safe and effective. For these patients, unless the tachycardia can be easily controlled with a minimal number of drugs and adverse effects, surgical ablation should be considered early in the clinical course.</div></front></TEI><istex><corpusName>elsevier</corpusName><author><json:item><name>David R. Holmes, Jr. MD</name><affiliations><json:string>Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA</json:string></affiliations></json:item><json:item><name>Gordon K. Danielson MD</name><affiliations><json:string>Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA</json:string></affiliations></json:item><json:item><name>Bernard J. Gersh MB, ChB, DPhil</name><affiliations><json:string>Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA</json:string></affiliations></json:item><json:item><name>Michael J. Osborn MD</name><affiliations><json:string>Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA</json:string></affiliations></json:item><json:item><name>Douglas L. Wood ND</name><affiliations><json:string>Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA</json:string></affiliations></json:item><json:item><name>Christopher Mclaran MD</name><affiliations><json:string>Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA</json:string></affiliations></json:item><json:item><name>Declan D. Sugrue MD, MRCP</name><affiliations><json:string>Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA</json:string></affiliations></json:item><json:item><name>Co-Burn J. Porter MD</name><affiliations><json:string>Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA</json:string></affiliations></json:item><json:item><name>Stephen C. Hammill MD</name><affiliations><json:string>Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA</json:string></affiliations></json:item></author><subject><json:item><lang><json:string>eng</json:string></lang><value>Arryhthmias and conduction disturbances</value></json:item></subject><articleId><json:string>85909634</json:string></articleId><language><json:string>eng</json:string></language><abstract>Twenty-seven patients aged 21 years or younger (mean 15) with symptomatic tachycardia underwent operation for ablation of an accessory atrioventricular pathway. Six patients had associated Ebstein's malformation of the tricuspid valve. Supraventricular tachycardia had been present for a mean of 5 years. At electrophysiologic study, 4 patients were found to have 2 accessory pathways. Left ventricular free wall pathways were found In 14 patients, right ventricular free wall pathways in 10 and septal pathways in 6. Successful initial ablation of all the pathways was achieved in 26 of the 27 patients. No patient died perioperatively and none had persistent complete heart block. During a mean follow-up of 11 months, no patient had recurrence of an arrhythmia related to the accessory pathway. Thus, the surgical treatment of children and young adults with accessory atrioventricular pathways and symptomatic supraventricular tachycardia is safe and effective. For these patients, unless the tachycardia can be easily controlled with a minimal number of drugs and adverse effects, surgical ablation should be considered early in the clinical course.</abstract><qualityIndicators><score>4.609</score><pdfVersion>1.3</pdfVersion><pdfPageSize>612 x 792 pts (letter)</pdfPageSize><refBibsNative>true</refBibsNative><keywordCount>1</keywordCount><abstractCharCount>1153</abstractCharCount><pdfWordCount>2557</pdfWordCount><pdfCharCount>18766</pdfCharCount><pdfPageCount>4</pdfPageCount><abstractWordCount>171</abstractWordCount></qualityIndicators><title>Surgical treatment of accessory atrioventricular pathways and symptomatic tachycardia in children and young adults</title><pii><json:string>0002-9149(85)90963-4</json:string></pii><genre><json:string>research-article</json:string></genre><serie><volume>57</volume><pages><last>350</last><first>345</first></pages><genre></genre><language><json:string>unknown</json:string></language><title>Mayo Clin Proc</title></serie><host><volume>55</volume><pii><json:string>S0002-9149(00)X0877-6</json:string></pii><pages><last>1512</last><first>1509</first></pages><issn><json:string>0002-9149</json:string></issn><issue>13</issue><genre><json:string>Journal</json:string></genre><language><json:string>unknown</json:string></language><title>The American Journal of Cardiology</title><publicationDate>1985</publicationDate></host><publicationDate>1985</publicationDate><copyrightDate>1985</copyrightDate><doi><json:string>10.1016/0002-9149(85)90963-4</json:string></doi><id>3B8186F6F2432D5880E5BAF6592D505D5D9A5479</id><fulltext><json:item><original>true</original><mimetype>application/pdf</mimetype><extension>pdf</extension><uri>https://api.istex.fr/document/3B8186F6F2432D5880E5BAF6592D505D5D9A5479/fulltext/pdf</uri></json:item><json:item><original>true</original><mimetype>text/plain</mimetype><extension>txt</extension><uri>https://api.istex.fr/document/3B8186F6F2432D5880E5BAF6592D505D5D9A5479/fulltext/txt</uri></json:item><json:item><original>false</original><mimetype>application/zip</mimetype><extension>zip</extension><uri>https://api.istex.fr/document/3B8186F6F2432D5880E5BAF6592D505D5D9A5479/fulltext/zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/document/3B8186F6F2432D5880E5BAF6592D505D5D9A5479/fulltext/tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main" xml:lang="en">Surgical treatment of accessory atrioventricular pathways and symptomatic tachycardia in children and young adults</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher>ELSEVIER</publisher><availability><p>ELSEVIER</p></availability><date>1985</date></publicationStmt><sourceDesc><biblStruct type="inbook"><analytic><title level="a" type="main" xml:lang="en">Surgical treatment of accessory atrioventricular pathways and symptomatic tachycardia in children and young adults</title><author><persName><forename type="first">David R.</forename><surname>Holmes, Jr.</surname></persName><roleName type="degree">MD</roleName><note type="biography">Address for reprints: David R. Holmes, Jr., MD, Mayo Clinic, 200 First Street SW, Rochester, Minnesota 55905.</note><affiliation>Address for reprints: David R. Holmes, Jr., MD, Mayo Clinic, 200 First Street SW, Rochester, Minnesota 55905.</affiliation><affiliation>Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA</affiliation></author><author><persName><forename type="first">Gordon K.</forename><surname>Danielson</surname></persName><roleName type="degree">MD</roleName><affiliation>Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA</affiliation></author><author><persName><forename type="first">Bernard J.</forename><surname>Gersh</surname></persName><roleName type="degree">MB, ChB, DPhil</roleName><affiliation>Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA</affiliation></author><author><persName><forename type="first">Michael J.</forename><surname>Osborn</surname></persName><roleName type="degree">MD</roleName><affiliation>Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA</affiliation></author><author><persName><forename type="first">Douglas L.</forename><surname>Wood</surname></persName><roleName type="degree">ND</roleName><affiliation>Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA</affiliation></author><author><persName><forename type="first">Christopher</forename><surname>Mclaran</surname></persName><roleName type="degree">MD</roleName><affiliation>Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA</affiliation></author><author><persName><forename type="first">Declan D.</forename><surname>Sugrue</surname></persName><roleName type="degree">MD, MRCP</roleName><affiliation>Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA</affiliation></author><author><persName><forename type="first">Co-Burn J.</forename><surname>Porter</surname></persName><roleName type="degree">MD</roleName><affiliation>Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA</affiliation></author><author><persName><forename type="first">Stephen C.</forename><surname>Hammill</surname></persName><roleName type="degree">MD</roleName><affiliation>Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA</affiliation></author></analytic><monogr><title level="j">The American Journal of Cardiology</title><title level="j" type="abbrev">AJC</title><idno type="pISSN">0002-9149</idno><idno type="PII">S0002-9149(00)X0877-6</idno><imprint><publisher>ELSEVIER</publisher><date type="published" when="1985"></date><biblScope unit="volume">55</biblScope><biblScope unit="issue">13</biblScope><biblScope unit="page" from="1509">1509</biblScope><biblScope unit="page" to="1512">1512</biblScope></imprint></monogr><idno type="istex">3B8186F6F2432D5880E5BAF6592D505D5D9A5479</idno><idno type="DOI">10.1016/0002-9149(85)90963-4</idno><idno type="PII">0002-9149(85)90963-4</idno><idno type="ArticleID">85909634</idno></biblStruct></sourceDesc></fileDesc><profileDesc><creation><date>1985</date></creation><langUsage><language ident="en">en</language></langUsage><abstract xml:lang="en"><p>Twenty-seven patients aged 21 years or younger (mean 15) with symptomatic tachycardia underwent operation for ablation of an accessory atrioventricular pathway. Six patients had associated Ebstein's malformation of the tricuspid valve. Supraventricular tachycardia had been present for a mean of 5 years. At electrophysiologic study, 4 patients were found to have 2 accessory pathways. Left ventricular free wall pathways were found In 14 patients, right ventricular free wall pathways in 10 and septal pathways in 6. Successful initial ablation of all the pathways was achieved in 26 of the 27 patients. No patient died perioperatively and none had persistent complete heart block. During a mean follow-up of 11 months, no patient had recurrence of an arrhythmia related to the accessory pathway. Thus, the surgical treatment of children and young adults with accessory atrioventricular pathways and symptomatic supraventricular tachycardia is safe and effective. For these patients, unless the tachycardia can be easily controlled with a minimal number of drugs and adverse effects, surgical ablation should be considered early in the clinical course.</p></abstract><textClass><keywords scheme="keyword"><list><head>Article category</head><item><term>Arryhthmias and conduction disturbances</term></item></list></keywords></textClass></profileDesc><revisionDesc><change when="1985-02-20">Registration</change><change when="1985-02-19">Modified</change><change when="1985">Published</change></revisionDesc></teiHeader></istex:fulltextTEI></fulltext><metadata><istex:metadataXml wicri:clean="Elsevier, elements deleted: tail"><istex:xmlDeclaration>version="1.0" encoding="UTF-8"</istex:xmlDeclaration><istex:docType PUBLIC="-//ES//DTD journal article DTD version 4.5.2//EN//XML" URI="art452.dtd" name="istex:docType"></istex:docType><istex:document><converted-article version="4.5.2" docsubtype="fla" xml:lang="en"><item-info><jid>AJC</jid><aid>85909634</aid><ce:pii>0002-9149(85)90963-4</ce:pii><ce:doi>10.1016/0002-9149(85)90963-4</ce:doi><ce:copyright type="unknown" year="1985"></ce:copyright><ce:doctopics><ce:doctopic><ce:text>Arryhthmias and conduction disturbances</ce:text></ce:doctopic></ce:doctopics></item-info><head><ce:title>Surgical treatment of accessory atrioventricular pathways and symptomatic tachycardia in children and young adults</ce:title><ce:author-group><ce:author><ce:given-name>David R.</ce:given-name><ce:surname>Holmes</ce:surname><ce:suffix>Jr.</ce:suffix><ce:degrees>MD</ce:degrees><ce:cross-ref refid="COR1"><ce:sup loc="post">∗</ce:sup></ce:cross-ref></ce:author><ce:author><ce:given-name>Gordon K.</ce:given-name><ce:surname>Danielson</ce:surname><ce:degrees>MD</ce:degrees></ce:author><ce:author><ce:given-name>Bernard J.</ce:given-name><ce:surname>Gersh</ce:surname><ce:degrees>MB, ChB, DPhil</ce:degrees></ce:author><ce:author><ce:given-name>Michael J.</ce:given-name><ce:surname>Osborn</ce:surname><ce:degrees>MD</ce:degrees></ce:author><ce:author><ce:given-name>Douglas L.</ce:given-name><ce:surname>Wood</ce:surname><ce:degrees>ND</ce:degrees></ce:author><ce:author><ce:given-name>Christopher</ce:given-name><ce:surname>Mclaran</ce:surname><ce:degrees>MD</ce:degrees></ce:author><ce:author><ce:given-name>Declan D.</ce:given-name><ce:surname>Sugrue</ce:surname><ce:degrees>MD, MRCP</ce:degrees></ce:author><ce:author><ce:given-name>Co-Burn J.</ce:given-name><ce:surname>Porter</ce:surname><ce:degrees>MD</ce:degrees></ce:author><ce:author><ce:given-name>Stephen C.</ce:given-name><ce:surname>Hammill</ce:surname><ce:degrees>MD</ce:degrees></ce:author><ce:affiliation><ce:textfn>Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA</ce:textfn></ce:affiliation><ce:correspondence id="COR1"><ce:label>∗</ce:label><ce:text>Address for reprints: David R. Holmes, Jr., MD, Mayo Clinic, 200 First Street SW, Rochester, Minnesota 55905.</ce:text></ce:correspondence></ce:author-group><ce:date-received day="29" month="10" year="1984"></ce:date-received><ce:date-revised day="19" month="2" year="1985"></ce:date-revised><ce:date-accepted day="20" month="2" year="1985"></ce:date-accepted><ce:abstract class="author"><ce:section-title>Abstract</ce:section-title><ce:abstract-sec><ce:simple-para view="all" id="simple-para.0010">Twenty-seven patients aged 21 years or younger (mean 15) with symptomatic tachycardia underwent operation for ablation of an accessory atrioventricular pathway. Six patients had associated Ebstein's malformation of the tricuspid valve. Supraventricular tachycardia had been present for a mean of 5 years. At electrophysiologic study, 4 patients were found to have 2 accessory pathways. Left ventricular free wall pathways were found In 14 patients, right ventricular free wall pathways in 10 and septal pathways in 6. Successful initial ablation of all the pathways was achieved in 26 of the 27 patients. No patient died perioperatively and none had persistent complete heart block. During a mean follow-up of 11 months, no patient had recurrence of an arrhythmia related to the accessory pathway. Thus, the surgical treatment of children and young adults with accessory atrioventricular pathways and symptomatic supraventricular tachycardia is safe and effective. For these patients, unless the tachycardia can be easily controlled with a minimal number of drugs and adverse effects, surgical ablation should be considered early in the clinical course.</ce:simple-para></ce:abstract-sec></ce:abstract></head></converted-article></istex:document></istex:metadataXml><mods version="3.6"><titleInfo lang="en"><title>Surgical treatment of accessory atrioventricular pathways and symptomatic tachycardia in children and young adults</title></titleInfo><titleInfo type="alternative" lang="en" contentType="CDATA"><title>Surgical treatment of accessory atrioventricular pathways and symptomatic tachycardia in children and young adults</title></titleInfo><name type="personal"><namePart type="given">David R.</namePart><namePart type="family">Holmes, Jr.</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA</affiliation><description>Address for reprints: David R. Holmes, Jr., MD, Mayo Clinic, 200 First Street SW, Rochester, Minnesota 55905.</description><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Gordon K.</namePart><namePart type="family">Danielson</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Bernard J.</namePart><namePart type="family">Gersh</namePart><namePart type="termsOfAddress">MB, ChB, DPhil</namePart><affiliation>Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Michael J.</namePart><namePart type="family">Osborn</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Douglas L.</namePart><namePart type="family">Wood</namePart><namePart type="termsOfAddress">ND</namePart><affiliation>Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Christopher</namePart><namePart type="family">Mclaran</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Declan D.</namePart><namePart type="family">Sugrue</namePart><namePart type="termsOfAddress">MD, MRCP</namePart><affiliation>Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Co-Burn J.</namePart><namePart type="family">Porter</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Stephen C.</namePart><namePart type="family">Hammill</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA</affiliation><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre type="research-article" displayLabel="Full-length article"></genre><originInfo><publisher>ELSEVIER</publisher><dateIssued encoding="w3cdtf">1985</dateIssued><dateValid encoding="w3cdtf">1985-02-20</dateValid><dateModified encoding="w3cdtf">1985-02-19</dateModified><copyrightDate encoding="w3cdtf">1985</copyrightDate></originInfo><language><languageTerm type="code" authority="iso639-2b">eng</languageTerm><languageTerm type="code" authority="rfc3066">en</languageTerm></language><physicalDescription><internetMediaType>text/html</internetMediaType></physicalDescription><abstract lang="en">Twenty-seven patients aged 21 years or younger (mean 15) with symptomatic tachycardia underwent operation for ablation of an accessory atrioventricular pathway. Six patients had associated Ebstein's malformation of the tricuspid valve. Supraventricular tachycardia had been present for a mean of 5 years. At electrophysiologic study, 4 patients were found to have 2 accessory pathways. Left ventricular free wall pathways were found In 14 patients, right ventricular free wall pathways in 10 and septal pathways in 6. Successful initial ablation of all the pathways was achieved in 26 of the 27 patients. No patient died perioperatively and none had persistent complete heart block. During a mean follow-up of 11 months, no patient had recurrence of an arrhythmia related to the accessory pathway. Thus, the surgical treatment of children and young adults with accessory atrioventricular pathways and symptomatic supraventricular tachycardia is safe and effective. For these patients, unless the tachycardia can be easily controlled with a minimal number of drugs and adverse effects, surgical ablation should be considered early in the clinical course.</abstract><subject><genre>Article category</genre><topic>Arryhthmias and conduction disturbances</topic></subject><relatedItem type="host"><titleInfo><title>The American Journal of Cardiology</title></titleInfo><titleInfo type="abbreviated"><title>AJC</title></titleInfo><genre type="Journal">journal</genre><originInfo><dateIssued encoding="w3cdtf">19850601</dateIssued></originInfo><identifier type="ISSN">0002-9149</identifier><identifier type="PII">S0002-9149(00)X0877-6</identifier><part><date>19850601</date><detail type="volume"><number>55</number><caption>vol.</caption></detail><detail type="issue"><number>13</number><caption>no.</caption></detail><extent unit="issue pages"><start>A15</start><end>A114</end></extent><extent unit="issue pages"><start>1453</start><end>1664</end></extent><extent unit="pages"><start>1509</start><end>1512</end></extent></part></relatedItem><identifier type="istex">3B8186F6F2432D5880E5BAF6592D505D5D9A5479</identifier><identifier type="DOI">10.1016/0002-9149(85)90963-4</identifier><identifier type="PII">0002-9149(85)90963-4</identifier><identifier type="ArticleID">85909634</identifier><recordInfo><recordContentSource>ELSEVIER</recordContentSource></recordInfo></mods></metadata><enrichments></enrichments></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000964 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 000964 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonV1
|flux= Main
|étape= Corpus
|type= RBID
|clé= ISTEX:3B8186F6F2432D5880E5BAF6592D505D5D9A5479
|texte= Surgical treatment of accessory atrioventricular pathways and symptomatic tachycardia in children and young adults
}}
| This area was generated with Dilib version V0.6.23. |  |